$603.01+35.19% · 3M
Moving avg
1W+3.96%
1M+12.91%
3M+34.54%
6M+18.28%
YTD+1.77%
1Y+24.39%
3Y+11.60%
5Y+10.72%
52-week range
$435.2780% of range$643.99
Company health
Value1/6
Growth4/6
Profitability4/6
Health4/6
Dividend4/6
Bull vs bear
Strengths
- Analyst consensus is "Buy"
- High return on equity (1335%)
Risks
No obvious red flags from the metrics.
Key statistics
Valuation
Market cap
$224.09B
Enterprise value
$249.66B
P/E ratio (TTM)
30.52x
P/S ratio (TTM)
4.56x
EV/EBITDA
22.83x
Per share & returns
EPS (TTM)
$18.81
Dividend yield
0.32%
Beta (1Y)
0.87
30-day change
+12.91%
Trading
Volume (24h)
0
Previous close
$605.00
Shares outstanding
371.62M
About Thermo Fisher Scientific Inc.
Sector
Healthcare
Industry
Medical - Diagnostics & Research
Exchange
NYSE
Symbol
TMO
Thermo Fisher Scientific Inc. is a mega-cap healthcare company in the Medical - Diagnostics & Research industry. Its shares are listed on NYSE (United States) and trade under the ticker TMO.
Frequently asked questions
What is Thermo Fisher Scientific Inc.'s market cap?
Thermo Fisher Scientific Inc. (TMO) has a market capitalization of $224.09B.
What is Thermo Fisher Scientific Inc.'s P/E ratio?
Thermo Fisher Scientific Inc. trades at a price-to-earnings (P/E) ratio of 30.52.
What exchange does TMO trade on?
TMO trades on NYSE.
Appears in
Compare & explore
Eli Lilly and CompanyLLY
$1,220.51+0.45%
$1.15T cap
Johnson & JohnsonJNJ
$260.86+0.41%
$628.65B cap
AbbVie Inc.ABBV
$248.66-0.57%
$439.33B cap
UnitedHealth Group IncorporatedUNH
$405.59+0.85%
$368.33B cap
Roche Holding AGSWX: ROP
CHF 365.50-0.92%
$358.08B cap
Merck & Co., Inc.MRK
$132.93+1.92%
$328.31B cap
Novartis AGSWX: NOVN
CHF 124.20-1.32%
$290.55B cap
AstraZeneca PLCLON: AZN
£117.02-1.20%
$244.81B cap